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Abstract
Background:  Indication-based data on the use of antimicrobials in animals were collected using a
prospective cross-sectional survey, similarly as for surveys carried out in human medicine, but adapting
the questionnaire to include veterinary-specific issues. The participating veterinarians were randomly
selected from a sample population of practising veterinarians. The sampling was stratified to take into
account the proportions of different types of veterinary practice in the country. All patients consulting the
veterinary practice during a 1-week period were included in the study and veterinarians returned a
completed questionnaire for each patient receiving antimicrobial treatment. As cattle received most of the
treatments, results from the survey are given using cattle as an example species.
Results:  The survey was sent to 681 veterinarians, of whom 262 (39%) responded. In total 2850
questionnaires were completed. The largest quantities of antimicrobials, measured in kilograms, were used
for cattle, followed by pigs, dogs and horses. The species that were treated most were cattle (n = 1308),
dogs (n = 989) and cats (n = 311). For cattle, the most common reason for treatment was acute mastitis
(52%), followed by dry-cow therapy (21%), subclinical mastitis (6%) and treatment for acute enteritis (4%).
The remaining treatments covered 17% of cattle patients and 15 different indications. For acute mastitis,
parenteral or intramammary treatment was used in 36% and 34% of the cases, respectively. The remaining
30% received both treatments simultaneously. Of the parenteral treatments (n = 459), benzyl penicillin
was used in 83% of the treated animals (n = 379), while fluoroquinolones were used in 49 cases (11%). Of
the 433 cows receiving intramammary treatment, ampicillin combined with cloxacillin was most commonly
used (n = 157; 36%), followed by cephalexin+streptomycin (n = 113; 26%).
Conclusion: This cross-sectional prospective survey provided a useful method for the collection of
information on the indication-based use of antimicrobials in different animal species. Cattle were the most
commonly treated animal species during the study period. The most common indication for antimicrobial
use in cows was mastitis. Benzyl penicillin was the drug most frequently used for the treatment of mastitis,
which seems appropriate according to the national guidelines on the use of antimicrobials in cattle in
Finland.
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Background
The lack of species-specific data on antimicrobial use has
been recognised as a major problem when trying to iden-
tify the relationship between use and the development of
resistance [1,2]. Several countries publish annual data on
the overall use of antimicrobials in the treatment of ani-
mal diseases [3-7]. However, those data only provide con-
sumption figures on a general level. More detailed
information is needed in order to understand better the
relationship between consumption; indicating the general
exposure of microbial flora to antimicrobials, and resist-
ance. Information on the use of antimicrobials in differ-
ent animal species on an indication basis would also
make it possible to evaluate how recommendations and
prudent use guidelines for antimicrobial use are being fol-
lowed.
Some studies have been carried out to collect more spe-
cific information on the use of antimicrobials in animals.
For example, Chauvin et al. (2005) [8] described continu-
ous monitoring of antimicrobial use in French poultry
production. Busani et al. (2004) [9] conducted a tele-
phone survey to evaluate how Italian veterinarians fol-
lowed guidelines for the judicious use of antimicrobials.
Some reports exist from Canada and the United States on
data collected from dairy farms [10-12] and data based on
wholesaler statistics from Norway and Sweden estimating
antimicrobial usage for mastitis are available [13]. To the
best of our knowledge, only Denmark collects detailed
data on a continuous basis, recording information about
the use of antimicrobials for different food-producing ani-
mals [4,14,15].
A cross-sectional prospective survey was previously suc-
cessfully carried out to investigate indication-based use of
antimicrobials in humans in Finland [16]. Our aim was to
collect data using a similar method, to analyse the distri-
bution of indication-based antimicrobial use among dif-
ferent animal species and to evaluate how the
recommendations for antimicrobial use are being fol-
lowed by veterinarians. The questionnaire was modified
to include veterinary-specific issues (Table 1). Here we
report the results as a descriptive analysis of indication-
based use of antimicrobials in cattle in Finland.
Results
Response rate and numbers of animals treated
A total of 262 of 681 (38%) veterinarians responded to
the questionnaire (Table 2). The representativeness of
respondents was tested for type of practice, geographical
area, gender, year of graduation, degree and field of spe-
cialisation. Those who responded represented the
intended sample well. The only statistically significant dif-
ference was noted in gender: female veterinarians
responded more actively than males (p < 0.05).
During the one-week survey, the responding veterinarians
used 51 kg of antimicrobials, most of this for cattle (30 kg;
59%), pigs (8 kg; 16%), dogs (6 kg; 12%) and horses (5
kg; 10%). The distribution of the different groups of anti-
microbials for each species is illustrated in Figure 1.
The 262 veterinarians that responded filled out question-
naires for a total of 2850 animals. Cattle were most com-
monly treated (n = 1308; 46%), followed by dogs (n =
989; 35%) and cats (n = 311; 11%). Six veterinarians
treated solely cattle and were responsible for the treat-
ments of 3.8% of all bovine cases. The remaining veteri-
narians also treated other animal species. As cattle were
the species receiving most treatments, results from the sur-
vey are given using cattle as an example species.
Table 1: Information collected in the survey on antimicrobial use and variables entered into the database
Data recoded Type of variable Description
1. Animal species Coded Dog, cat, horse, cattle, pig, fur animals, fish, other
2. Type of visit Coded Normal daytime visit, on-call visit or prescription 
by phone
3. Main diagnosis Coded 18 pre-coded alternatives and possibility to give 
own diagnosis if something else
4. Duration of clinical signs Coded 0–3, 4–7, 8–14 days or longer
5. Clinical examination or diagnostic tests carried out Coded 8 pre-coded alternatives and possibility to describe 
other tests or procedures
6. Antimicrobial drug administered by veterinarian Text Product name and strength; amount given
7. Antimicrobial drug given to the owner to continue the treatment (per 
oral or injectable)
Text Product name and strength; duration of treatment
8. Antimicrobial drug given to the owner to continue the treatment 
(local treatment, including intramammaries)
Text Product name and strength; duration of treatment
9. Was the choice of product used affected by allergy, other disease, 
owner's wishes, recurrent or chronic infection or something else?
Coded
10. Was this the first visit or a follow-up visit? CodedBMC Veterinary Research 2008, 4:15 http://www.biomedcentral.com/1746-6148/4/15
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Antimicrobial usage in cattle
During the study period, a total of 1308 cattle were treated
with antimicrobials. The most common diagnosis was
acute mastitis (n = 686; 52%), followed by dry-cow ther-
apy (n = 271; 21%), subclinical mastitis (n = 78; 6%) and
acute enteritis (n = 49; 4%). The remaining treatments (n
= 224; 17%) were distributed among 15 indications with
the number of animals treated falling below 40 in each
indication (abscess, septic arthritis, retained placenta
etc.). The proportions of different antimicrobials used in
cattle are presented in Figure 1. Of a total of 1035 treat-
ments for mastitis, one third (n = 337) were prescribed by
telephone to pharmacies. In dry-cow therapy almost half
of the prescriptions were of this type (139 of 271) and all
were intramammary treatments. For 10 cows (4%) an
injectable preparation was prescribed by phone and seven
of these were from the same herd.
Acute mastitis
Most veterinarians (37%) based the diagnosis of acute
mastitis on clinical signs, results from the California Mas-
titis Test (CMT) and bacteriological culture (Figure 2).
Most of the cows (482 of 686; 70%) had shown clinical
signs of mastitis for 0–3 days before treatment. Eighteen
percent (n = 122) showed some signs for 4–7 days before
any treatment was initiated. The treatment regimen was
documented for 679 animals (99%). Either parenteral
treatment by intramuscular injection (n = 246; 36%) or
intramammary treatment (n = 234; 34%) was used. A
combination of parenteral and intramammary treatment
was used in the remaining cases (n = 199). Thirteen ani-
mals (2%) were simultaneously treated with 2 or 3
parenteral preparations.
The most commonly used antimicrobial for parenteral
treatment was benzyl penicillin (n = 379; 83%). Fluoro-
quinolones (enrofloxacin or danofloxacin) were used in
49 (11%) cases. Some cows were also treated with tri-
methoprim-sulfonamides (n = 20), oxytetracycline (n = 7)
or spiramycin (n = 4). Of the 433 cows that received
intramammary treatment, a product containing ampicil-
lin and cloxacillin was the most commonly used (n = 157;
36%). Another frequently used product contained
cephalexin and streptomycin (n = 113; 26%).
The duration of treatment was recorded for 413 cows
treated parenterally and for 401 cows with intramammary
treatment. In both groups the prescribed treatment length
(median) was 4 days (43% and 41% respectively, range in
both 1–8 days).
Distribution of antimicrobial substances used for different  animal species during the one-week study period Figure 1
Distribution of antimicrobial substances used for dif-
ferent animal species during the one-week study 
period. 'Others' includes cats, fur animals, rabbits, small 
rodents and reptiles.
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
Cattle
(30 kg)
Swine
(8 kg)
Dogs
(6 kg)
Horses
(5 kg)
Others
(2 kg)
Fluoroquinolones
Tetracyclines
Trimethoprim-
sulfonamides
Aminoglycosides
β-lactams
Table 2: Background information on the veterinary practitioners
Type of practice among those 
participating in the survey
Number of members 
(% of all members in 
practice)
Sample size 
(% of members in the 
named group)
Number of respondents 
(% of sampled practitioners 
in the group)
% of all 
respondents 
(n = 262)
Community/county veterinarian in 
countryside
233 (27%) 176 (76%) 73 (41%) 27.9
Community/county veterinarian 
working in city
119 (14%) 91 (76%) 35 (38%) 13.4
Community/county head of health 
services
13 (2%) 13 (100%) 9 (69%) 3.4
Government or Helsinki University 80 (9%) 42 (53%) 19 (45%) 7.3
Private practitioner 180 (21%) 132 (73%) 48 (36%) 18.3
Veterinarians with non-permanent 
positions
141 (16%) 136 (96%) 47 (35%) 17.9
Student with right to practice the 
profession
92 (11%) 91 (99%) 31 (34%) 11.8
Total 858 681 (79%) 262 (38%) 100BMC Veterinary Research 2008, 4:15 http://www.biomedcentral.com/1746-6148/4/15
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Subclinical mastitis
A total of 78 cows were diagnosed as having subclinical
mastitis during the study period. In 55 cows (71%), bac-
terial culture was used for diagnosis. Most of the cows
(74%) were treated with intramammary preparations
alone. As for acute mastitis, the most commonly used
intramammaries were those containing cephalexin and
streptomycin (35%), followed by ampicillin and cloxacil-
lin (18%). The prescribed duration of treatment ranged
from 1 to 8 days, and the median duration was 4 days.
Dry cow therapy
Cows were selected for dry cow therapy on the basis of
bacterial culture of milk in 41% (110 out of 271) of the
cases. In 50 more cases, the veterinarian reported the use
of the CMT as a diagnostic tool.
The vast majority of the dry cow therapies were intramam-
mary treatments (94%). Of the 254 intramammary dry
cow treatments, either cloxacillin alone or combined with
ampicillin (n = 127; 50%), or a β-lactam combined with
an aminoglycoside (n = 109; 43%) was used. A little over
half of the medications were dispensed via telephone pre-
scriptions (n = 139; 55%).
Discussion
This cross-sectional prospective survey, using a method
adapted from human medicine [16], represented a useful
method for collecting information on the indication-
based use of antimicrobials in animals. The response rate
of almost 40% can be considered reasonably high, taking
into account that completion of a survey questionnaire
represents an additional burden for busy practitioners.
The respondents represented the original sample very well
(Table 2), which shows that the weighted stratification
was successful.
The questionnaire functioned well. However, we identi-
fied a few items that could be added to obtain more infor-
mation. For example, the weight of the animal should be
recorded to calculate the actual dose used for the treat-
ment. Information on the results from bacteriological cul-
tures would improve the evaluation of how the guidelines
were followed by the veterinarians. Antimicrobial drugs
administered or dispensed (points 6–8 in the question-
naire, Table 1) could be combined in order to simplify the
form. Having an electronic form could make the survey
more user-friendly and also facilitate compiling the infor-
mation supplied.
Mastitis was by far the most common indication for the
use of antimicrobial agents in our study, as 79% of all the
cows were treated for mastitis. This is consistent with pre-
vious studies [12,13,17]. Acute mastitis was most com-
monly treated within the first three days following the
onset of clinical signs, but sometimes a cow was treated
no earlier than 4–7 days after the appearance of the clini-
cal signs. The urgency of the treatment should depend on
the severity of the infection. In a recent study, a 24-h delay
was found not to affect the therapy response of clinical
mastitis with mild to moderate clinical signs [18]. The
median length of treatment prescribed by the veterinari-
ans was 4 days for all routes of administration. This is in
line with the recommendations, which suggest a course of
treatment of 3–5 days, independent of the treatment regi-
men used [19]. However, performing follow-up on owner
compliance to complete the started or prescribed course
of treatment was beyond the scope of this study.
The recommended practice in acute mastitis is to perform
a clinical examination and the CMT and to take a milk
sample for bacterial culture. Empiric treatment is initiated
and directed towards the most probable causative patho-
gen [19]. This survey showed that only 37% of veterinari-
ans used the recommended methods to make treatment
decisions (Figure 2). In the majority of cases (73%) of
subclinical mastitis, veterinarians used bacteriological
diagnosis to target the treatment, as treatment could be
postponed until results from the bacteriological culture
were available. Dry cow therapy was based on bacteriolog-
ical results in only 41% of cases. Bacteriological diagnosis
as a basis for mastitis treatment could be used more fre-
quently than was indicated in this survey.
National guidelines for the use of antimicrobials in ani-
mals have been provided by the Finnish Veterinary Anti-
microbial Advisory Group of the Ministry of Agriculture
and Forestry [20]. In Finland, half of acute mastitis cases
are caused by staphylococci and streptococci [21]. The
Methods applied by veterinarians to diagnose acute bovine  mastitis Figure 2
Methods applied by veterinarians to diagnose acute 
bovine mastitis. C = clinical signs, B = bacteriological cul-
ture and sensitivity testing, CMT = California Mastitis Test, 
not recorded = no diagnostics were used or none recorded.
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national guidelines suggest that acute mastitis caused by
streptococci and β-lactamase-negative staphylococci
should be treated with benzyl penicillin. In our survey,
systemic treatment with β-lactams, mainly benzyl penicil-
lin, was used for acute mastitis in the majority of cases.
Drug selection thus accorded well with the recommenda-
tions, but the route of administration did not. Systemic
treatment of acute mastitis is still common practice in all
Nordic countries [13], despite the lack of evidence of its
superiority over intramammary treatment [19]. About
30% of acute mastitis was treated using concomitant
parenteral and intramammary treatment. Better efficacy of
this regimen could be expected for deep infections such as
mastitis caused by Staphylococcus aureus, but in mild to
moderate clinical mastitis intramammary treatment is
mostly sufficient [19,22]. Consumption of antimicrobials
is much higher if parenteral or combination treatment is
used for the routine treatment of mastitis.
Fluoroquinolones, which are the drugs of choice for
severe coliform mastitis, were used in 11% of parenteral
treatments for acute mastitis. About twelve percent of
acute mastitis cases in Finland are caused by coliforms
[21], so the use of fluoroquinolones reflected this propor-
tion if targeted at these cases. The use of fluoroquinolo-
nes, particularly in food-producing animals, should be
kept to a minimum to avoid the emergence of resistance
[23]. Cattle are food-producing animals, which limits the
variety of drugs that are approved for the treatment of
infectious diseases. In Finland, the use of antimicrobial
agents is further restricted by national regulations so that,
for example, the use of 3rd and 4th generation cepha-
losporins in cattle is not permitted.
In order to further evaluate how closely the guidelines
were followed when treating an individual patient, the
results of bacteriological cultures would have been
needed.
Conclusion
This cross-sectional prospective survey proved useful in
collecting indication-based data on the use of antimicro-
bials in animals. The response rate of veterinarians was
39%, which can be considered satisfactory. The most com-
mon indication for antimicrobial use was mastitis in cat-
tle. Benzyl penicillin was the most commonly used drug.
The first-line treatment of mastitis was in accordance with
the national guidelines, except for the route of administra-
tion. The use of bacteriological diagnosis to target treat-
ment was sub-optimal.
Methods
Prospective cross-sectional survey
The data were collected using a prospective cross-sectional
survey according to the principles of surveys carried out in
human medicine [16]. The questionnaire in our survey
was modified to take into account the veterinary-specific
issues.
In Finland 96% of the veterinarians are members of the
Finnish Veterinary Association. The sample population
comprised practising veterinarians (n = 858) and by using
the computerised register of members, a random sam-
pling of veterinarians (n = 681) was carried out. Non-prac-
tising veterinarians were excluded. The sampling was
weighted in order to take into account the proportions of
different types of veterinary practice to obtain a represent-
ative sample of each stratum (Table 2).
A letter explaining the study protocol and a sheet for col-
lection of background information was sent to each par-
ticipating practitioner with 20 questionnaire sheets. More
could be copied if needed. The following data were col-
lected from each practitioner as background information:
geographical area (province), gender, year of graduation,
degree and field of specialisation. The background sheet
was numbered, indicating the stratum to which the veter-
inarian belonged.
Veterinarians were asked to complete one questionnaire
sheet for every animal that received antimicrobial treat-
ment during the 7-day (Monday to Sunday, one week in
May) study period. The contents of the questionnaire are
listed in Table 1. If the same treatment was carried out for
several animals of the same species at one occasion, only
one sheet was filled out, supplemented with the number
of animals treated. When analysing the data, treatment for
each animal was counted separately. The duration of clin-
ical signs was estimated by the veterinarian according to
the history provided by the animal owners. The duration
of the treatment was the same as the prescribed length of
the treatment.
Veterinarians had a possibility to reply anonymously. To
motivate the practitioners to return the questionnaires,
every respondent received feedback about the results of
the study, and three travel gift certificates were also raffled
between those who responded. Contact details were col-
lected for this purpose.
Data analysis
The distribution of the different practice types was com-
pared with that of the source population. The following
characteristics of the respondents were analysed: type of
practice (stratum), geographical area, gender, year of grad-
uation, degree and field of specialisation. The representa-
tiveness of the respondents compared with the original
sample was analysed with a X2-test. The level of signifi-
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Precoded information from the questionnaires was intro-
duced into a database in ASCII-format. Text fields describ-
ing the antimicrobial products were coded by taking into
consideration whether the preparation used was a human
or a veterinary product, the formulation and which group
of antimicrobial substances it belonged to. A descriptive
analysis of the distributions of antimicrobial use in differ-
ent indications was performed. Both SAS (version 9.1, SAS
Institute Inc, Cary, NC) and Microsoft Excel (version 10,
Microsoft Corporation, Redmond, WA, USA) pro-
grammes were used for data analysis.
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